Rating History for Nektar Therapeutics (NKTR) by JPMorgan
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 8/21/2026 | Jessica Fye | New Coverage | Neutral (N/A) |
65.00 (N/A) |
76.08 (71.80) |
-5.63% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 8/21/2026 | Jessica Fye | New Coverage | Neutral (N/A) |
65.00 (N/A) |
76.08 (71.80) |
-5.63% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||